4/A//SEC Filing
Day Lucy 4/A
Accession 0001610717-24-000195
CIK 0001880438other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:18 PM ET
Size
4.6 KB
Accession
0001610717-24-000195
Insider Transaction Report
Form 4/AAmended
Day Lucy
Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-15+27,500→ 30,627 total
Footnotes (1)
- [F1]Previously reported on a Form 4 filed on March 18, 2024. As amended, the vesting schedule for the restricted stock units is as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914510
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:18 PM ET
- Size
- 4.6 KB